Mike Lynch is accused of overinflating the value of his firm Autonomy when he sold it to Hewlett-Packard.
Source link
AstraZeneca pauses £200m Cambridge investment
Mitchell LabiakBusiness reporter andSimon JackBusiness editorGetty ImagesAstraZeneca has paused plans to invest £200m at a Cambridge research site in...